105 related articles for article (PubMed ID: 7828294)
1. Role of cardiac beta 2-receptors in cardiac responses to exercise in cardiac transplant patients.
Leenen FH; Davies RA; Fourney A
Circulation; 1995 Feb; 91(3):685-90. PubMed ID: 7828294
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
3. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
Ferro A; Hall JA; Dickerson JE; Brown MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
[TBL] [Abstract][Full Text] [Related]
6. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
7. Exercise tolerance after beta blockade in recent cardiac transplant recipients.
Buendía Fuentes F; Almenar Bonet L; Martínez-Dolz L; Sancho-Tello de Carranza MJ; Moro López J; Agüero Ramón-Llin J; Sánchez-Lázaro I; Sánchez-Gómez JM; Raso Raso R; Navarro Manchón J; Salvador Sanz A
Transplant Proc; 2009; 41(6):2250-2. PubMed ID: 19715889
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.
Vandongen R; Margetts B; Beilin LJ; deKlerk N; Rogers P
Eur J Clin Pharmacol; 1986; 30(3):283-7. PubMed ID: 2874032
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
10. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
11. Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.
Jimenez AH; Tofler GH; Chen X; Stubbs ME; Solomon HS; Muller JE
Am J Cardiol; 1993 Jul; 72(1):47-52. PubMed ID: 8517427
[TBL] [Abstract][Full Text] [Related]
12. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
Wilcox RG; Hampton JR
Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
[TBL] [Abstract][Full Text] [Related]
13. Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans.
Maman SR; Vargas AF; Ahmad TA; Miller AJ; Gao Z; Leuenberger UA; Proctor DN; Muller MD
J Appl Physiol (1985); 2017 Aug; 123(2):337-343. PubMed ID: 28572492
[TBL] [Abstract][Full Text] [Related]
14. Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantation.
Yusuf S; Theodoropoulos S; Dhalla N; Mathias CJ; Teo KK; Wittes J; Yacoub M
Am J Cardiol; 1989 Sep; 64(10):636-41. PubMed ID: 2571288
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
[TBL] [Abstract][Full Text] [Related]
16. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
[TBL] [Abstract][Full Text] [Related]
17. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
Head A; Maxwell S; Kendall MJ
Br J Sports Med; 1997 Jun; 31(2):120-5. PubMed ID: 9192124
[TBL] [Abstract][Full Text] [Related]
18. Hypertension, exercise, and beta-adrenergic blockade.
Ades PA; Gunther PG; Meacham CP; Handy MA; LeWinter MM
Ann Intern Med; 1988 Oct; 109(8):629-34. PubMed ID: 2901818
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocker duration of action and implications for therapy.
Kostis JB
Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
[TBL] [Abstract][Full Text] [Related]
20. Cardio-protection afforded by β-blockade is maintained during resistance exercise.
Conviser JM; Ng AV; Rockey SS; Thomas DP
J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
